T-Heart
PrivateCompany Overview
T-Heart is a medical device company developing a novel transcatheter prosthetic heart valve for the treatment of tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
transcatheter tricuspid valve replacementTTVRstructural heart devicetricuspid regurgitationTRprosthetic heart valvemedtechheart valve replacementminimally invasive surgeryinterventional cardiologytranscatheter delivery systemmedical device
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-Heart Comparables
Compare T-Heart with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VDyne | 93% | |
| Trisol Medical | 91% | |
| Laplace Interventional | 89% | |
T-Heart Funding Rounds
Historical fundraising activity
T-Heart Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iBionext | Seed, Series A |
T-Heart Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about T-Heart's valuation, stock price, and market status.